Witnessing the stock’s movement on the chart, on Wednesday, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) had a quiet start as it plunged -1.61% to $24.44, before settling in for the price of $24.84 at the close. Taking a more long-term approach, TEVA posted a 52-week range of $12.47-$26.38.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -9.65%. Meanwhile, its Annual Earning per share during the time was -9.65%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 6.98%. This publicly-traded company’s shares outstanding now amounts to $1.15 billion, simultaneously with a float of $1.15 billion. The organization now has a market capitalization sitting at $28.03 billion. At the time of writing, stock’s 50-day Moving Average stood at $20.70, while the 200-day Moving Average is $17.56.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – Specialty & Generic industry. Teva- Pharmaceutical Industries Ltd. ADR’s current insider ownership accounts for 0.15%, in contrast to 58.25% institutional ownership. According to the most recent insider trade that took place on Nov 14 ’25, this organization’s EVP, Head of U.S. Commercial sold 30,000 shares at the rate of 25.11, making the entire transaction reach 753,321 in total value, affecting insider ownership by 28,384.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Earnings and Revenue Records
Teva- Pharmaceutical Industries Ltd. ADR’s EPS increase for this current 12-month fiscal period is 6.98% and is forecasted to reach 2.82 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 8.37% through the next 5 years, which can be compared against the -9.65% growth it accomplished over the previous five years trading on the market.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Trading Performance Indicators
Let’s observe the current performance indicators for Teva- Pharmaceutical Industries Ltd. ADR (TEVA). It’s Quick Ratio in the last reported quarter now stands at 0.82. Alongside those numbers, its PE Ratio stands at $39.92, and its Beta score is 0.61. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.66. Similarly, its price to free cash flow for trailing twelve months is now 111.58.
In the same vein, TEVA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.61, a figure that is expected to reach 0.67 in the next quarter, and analysts are predicting that it will be 2.82 at the market close of one year from today.
Technical Analysis of Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
Going through the that latest performance of [Teva- Pharmaceutical Industries Ltd. ADR, TEVA]. Its last 5-days volume of 11.95 million indicated improvement to the volume of 11.9 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 41.91% While, its Average True Range was 61.73.
Raw Stochastic average of Teva- Pharmaceutical Industries Ltd. ADR (TEVA) in the period of the previous 100 days is set at 82.97%, which indicates a major rise in contrast to 69.71% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.90 that was higher than 0.55 volatility it exhibited in the past 100-days period.
